20-11: Clinigen to Amerisur Resources


As one of the runaway stocks of 2013, Aim success story Clinigen (CLIN) finally saw its share price lose momentum at the start of 2014. After the share price rose from 200p to more than 600p over the course of last year, the latest set of results from the speciality pharma group panicked investors. The shares crashed 17 per cent in early trading on the morning the half-year results were released, as the group revealed current profit margins were unsustainable.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now